株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

眼科関連企業の契約動向調査:ベンチャー資金・民間資金・事業&技術買収

2018/2019 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales

発行 Market Scope, LLC 商品コード 644816
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.87円で換算しております。
Back to Top
眼科関連企業の契約動向調査:ベンチャー資金・民間資金・事業&技術買収 2018/2019 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales
出版日: 2019年12月23日 ページ情報: 英文
概要

当レポートでは、眼科関連産業における投資動向を調査し、眼科関連企業による資金調達の現状、資金タイプ・投資家タイプの種類と概要、主な資金投入企業のプロファイル、近年の資金調達・投資・事業&技術買収契約の動向などをまとめています。

イントロダクション

定義

エグゼクティブサマリー

  • 眼科関連企業による資金調達:資金タイプ別
  • 眼科関連産業への投資:投資家タイプ別

資金投入企業のプロファイル

  • 企業名
  • 本部・コンタクト情報
  • 資金調達実績
  • 資金源
  • 総調達額
  • 創立年
  • 所有区分 (民間・公共)
  • 従業員数
  • 主要幹部
  • プロジェクト・製品のプロファイル
  • 企業の背景
  • 主なマイルストーン・タイムライン
  • 財務概要
  • 企業の展望

眼科関連産業への戦略的投資

眼科関連産業へのプライベートエクイティ投資

近年のベンチャーキャピタル投資家

眼科関連産業への投資の展望

目次

Our 2018/2019 Ophthalmic Deals Book covers 108 ophthalmic company transactions in 2018 and 2019, including investments by venture capital firms, private equity, public stock offerings, and sales of companies. There are many new features in the 2019 version of this report, including a detailed analysis of each ophthalmic sector. This analysis reviews sector transaction counts and totals, sector allocation compared with other ophthalmic sectors, sector funds by use and type, and the top funded companies in each sector.

Also new in the 2019 version is an analysis of NIH and other grants to ophthalmology. A comprehensive list of retinal disease gene therapies in development and an additional 57 tables and figures are also new in 2019.

What's New

Our 2018/2019 Ophthalmic Deals Book covers 108 ophthalmic company transactions in 2018 and 2019, including investments by venture capital firms, private equity, public stock offerings, and sales of companies. There are many new features in the 2019 version of this report, including a detailed analysis of each ophthalmic sector. This analysis reviews sector transaction counts and totals, sector allocation compared with other ophthalmic sectors, sector funds by use and type, and the top funded companies in each sector.

Market Scope's "2018/20198 Ophthalmic Deals Book" analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures. The information covers investments in ophthalmic ventures in 2018 and the first 10 months of 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. Also included:

  • Transactions categorized by fund use: new venture, commercial equity, sale of companies, and license payments.
  • Four investment types are analyzed in this report: strategic investors, venture capital, public offerings, and private equity.
  • Detailed transaction analysis provided for seven ophthalmic sectors: dry eye, retina, glaucoma, cataract, diagnostic, cornea, and refractive. Key investors and transactions in each sector are included.
  • Key metrics in this report include: companies raising funds, companies making investments, and top funded companies.
  • Company coverage: 78 companies, along with total funds earned, are included in the report; company profiles are provided for 46 companies that raised greater than the median deal size.

image1

Also new in the 2019 version is an analysis of NIH and other grants to ophthalmology. A comprehensive list of retinal disease gene therapies in development and an additional 57 tables and figures are also new in 2019.

Back to Top